When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar Bio up 11% premarket on Orphan Drug tag for CLR 131 in LPL
Cellectar Biosciences Inc.
Thinly traded nano cap Cellectar Biosciences (NASDAQ:CLRB) perks up 11% premarket on average volume in reaction to Orphan Drug designation in the U.S. for CLR 131 for slow-growing type of non-Hodgkin lymphoma called lymphoplasmacytic lymphoma (LPL).
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,